Redhill Biopharma Ltd
NASDAQ:RDHL
Redhill Biopharma Ltd
Net Change in Cash
Redhill Biopharma Ltd
Net Change in Cash Peer Comparison
Competitive Net Change in Cash Analysis
Latest Figures & CAGR of Competitors
Company | Net Change in Cash | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Redhill Biopharma Ltd
NASDAQ:RDHL
|
Net Change in Cash
-$20m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-15%
|
|
Teva Pharmaceutical Industries Ltd
TASE:TEVA
|
Net Change in Cash
$815m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
8%
|
CAGR 10-Years
N/A
|
|
Taro Pharmaceutical Industries Ltd
NYSE:TARO
|
Net Change in Cash
$208.4m
|
CAGR 3-Years
31%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
I
|
InterCure Ltd
TASE:INCR
|
Net Change in Cash
-₪131.5m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-48%
|
Mediwound Ltd
NASDAQ:MDWD
|
Net Change in Cash
-$22m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
6%
|
CAGR 10-Years
N/A
|
|
R
|
Rekah Pharmaceutical Industry Ltd
TASE:REKA
|
Net Change in Cash
-₪898k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Redhill Biopharma Ltd's Net Change in Cash?
Net Change in Cash
-20m
USD
Based on the financial report for Dec 31, 2023, Redhill Biopharma Ltd's Net Change in Cash amounts to -20m USD.
What is Redhill Biopharma Ltd's Net Change in Cash growth rate?
Net Change in Cash CAGR 10Y
-15%
Over the last year, the Net Change in Cash growth was -110%.